Singapore approves S$6 billion from past reserves to fund a “multi-pronged approach”, aiming to continue supporting COVID-19 public health expenditure for financial year 2022. Despite preparing for a new normal transition, Singapore still considers that it is not yet time to spare efforts in areas such as testing, clinical management, vaccination, and therapeutics. This is the third consecutive financial year that Singapore has had to draw on past reserves to battle COVID-19.
For more information, read the full news article originally published in CNA.
Have anything to say about Singapore’s health financing and social health protection? Please leave your comments below.
Picture by patpitchaya
